Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Grundy, J. Cleeman, S. Daniels, K. Donato, R. Eckel, B. Franklin, D. Gordon, R. Krauss, P. Savage, Sidney Smith, J. Spertus, F. Costa (2005)
Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific StatementCirculation, 112
(2004)
Use and abuse of HOMA modelling. Diabetes Care 2004;27:1487-95
L. Cigliano, M. Spagnuolo, G. Cuomo, G. Valentini, A. Niglio, P. Abrescia (2005)
Apolipoprotein A-I-dependent cholesterol esterification in patients with rheumatoid arthritis.Life sciences, 77 1
A. Chobanian, G. Bakris, H. Black, W. Cushman, L. Green, J. Izzo, Daniel Jones, B. Materson, S. Oparil, J. Wright, E. Roccella (2003)
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.Hypertension, 42 6
Y. Shoenfeld, R. Gerli, A. Doria, E. Matsuura, M. Cerinic, N. Ronda, L. Jara, M. Abu-Shakra, P. Meroni, Y. Sherer (2005)
Accelerated Atherosclerosis in Autoimmune Rheumatic DiseasesCirculation, 112
N. Sattar, D. Mccarey, H. Capell, I. McInnes (2003)
Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis.Circulation, 108 24
M. Lazarevic, M. Lazarevic, Jelena Vitic, V. Mladenovic, B. Myones, J. Skosey, W. Swedler (1992)
Dyslipoproteinemia in the course of active rheumatoid arthritis.Seminars in arthritis and rheumatism, 22 3
S. Cobb, F. Anderson, W. Bauer (1953)
Length of life and cause of death in rheumatoid arthritis.The New England journal of medicine, 249 14
S. Doornum, G. McColl, I. Wicks (2002)
Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?Arthritis and rheumatism, 46 4
D. Aletaha, M. Ward, K. Machold, V. Nell, T. Stamm, J. Smolen (2005)
Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states.Arthritis and rheumatism, 52 9
R. Ranza, A. Marchesoni, G. Calori, Gerolamo Bianchi, M. Braga, S. Canazza, B. Canesi, M. Fumagalli, C. Mastaglio, Alessandro Mathieu, F. Fantini (1993)
The Italian version of the Functional Disability Index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis.Clinical and experimental rheumatology, 11 2
S. Grundy, J. Cleeman, S. Daniels, K. Donato, R. Eckel, B. Franklin, D. Gordon, R. Krauss, P. Savage, Sidney Smith, J. Spertus, F. Costa (2005)
Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive SummaryCardiology in Review, 13
Maini Rn (1996)
The Role of Cytokines in Rheumatoid ArthritisJournal of the Royal College of Physicians of London, 30
L. Chambless, M. Zhong, D. Arnett, A. Folsom, W. Riley, G. Heiss (1996)
Variability in B-mode ultrasound measurements in the atherosclerosis risk in communities (ARIC) study.Ultrasound in medicine & biology, 22 5
G. Cuomo, P. Micco, A. Niglio, G. Montagna, G. Valentini (2011)
[Atherosclerosis and rheumatoid arthritis: relationships between intima-media thickness of the common carotid arteries and disease activity and disability].Reumatismo, 56 4
József Lakatos, Ágnes Hárságyi (1988)
Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis.Clinical biochemistry, 21 2
N. Goodson (2002)
Coronary artery disease and rheumatoid arthritisCurrent Opinion in Rheumatology, 14
S. Grundy, J. Cleeman, S. Daniels, K. Donato, R. Eckel, B. Franklin, D. Gordon, R. Krauss, P. Savage, Sidney Smith, J. Spertus, F. Costa (2005)
Diagnosis and management of the metabolic syndromeCardiology in Review, 13
R. Hällgren, C. Berne (2009)
Glucose intolerance in patients with chronic inflammatory diseases is normalized by glucocorticoids.Acta medica Scandinavica, 213 5
E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, J. Meigs, R. Bonadonna, M. Muggeo (2007)
Insulin Resistance as Estimated by Homeostasis Model Assessment Predicts Incident Symptomatic Cardiovascular Disease in Caucasian Subjects From the General PopulationDiabetes Care, 30
T. Pettersson, C. Friman, L. Abrahamsson, B. Nilsson, B. Norberg (1998)
Serum homocysteine and methylmalonic acid in patients with rheumatoid arthritis and cobalaminopenia.The Journal of rheumatology, 25 5
S. Wållberg-Jonsson, M. Cederfelt, S. Dahlqvist (2000)
Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year followup study.The Journal of rheumatology, 27 1
P. Dessein, M. Tobias, M. Veller (2006)
Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis.The Journal of rheumatology, 33 12
S. Wållberg-Jonsson, H. Johansson, Marie-Louise Öhman, S. Rantapää-Dahlqvist (1999)
Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.The Journal of rheumatology, 26 12
J. Levy, D. Matthews, M. Hermans (1998)
Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer ProgramDiabetes Care, 21
G. Paolisso, G. Valentini, D. Giugliano, G. Marrazzo, R. Tirri, M. Gallo, G. Tirri, M. Varricchio, F. D'onofrio (1991)
Evidence for peripheral impaired glucose handling in patients with connective tissue diseases.Metabolism: clinical and experimental, 40 9
G. Howard, A. Sharrett, G. Heiss, G. Evans, L. Chambless, W. Riley, G. Burke (1993)
Carotid Artery Intimal‐Medial Thickness Distribution in General Populations As Evaluated by B‐Mode UltrasoundStroke, 24
F. Arnett, S. Edworthy, D. Bloch, D. McShane, J. Fries, N. Cooper, L. Healey, S. Kaplan, M. Liang, H. Luthra, T. Medsger, D. Mitchell, D. Neustadt, R. Pinals, J. Schaller, J. Sharp, R. Wilder, G. Hunder (1988)
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis and rheumatism, 31 3
P. Dessein, B. Joffe, A. Stanwix (2002)
Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot studyArthritis Research, 4
A. Hanley, K. Williams, M. Stern, S. Haffner (2002)
Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.Diabetes care, 25 7
I. Rincón, D. O'leary, Roy Haas, A. Escalante (2004)
Effect of glucocorticoids on the arteries in rheumatoid arthritis.Arthritis and rheumatism, 50 12
A. Mcentegart, H. Capell, D. Creran, A. Rumley, M. Woodward, G. Lowe (2001)
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis.Rheumatology, 40 6
Martin Veller, Charles Fisher, Andrew Nicolaides, Sophie Renton, G. Geroulakos, Nicolas Stafford, Ajanta Sarker, Gabriel Szendro, Gianni Belcaro (1993)
Measurement of the ultrasonic intima-media complex thickness in normal subjects.Journal of vascular surgery, 17 4
F. Arnett (1990)
Revised criteria for the classification of rheumatoid arthritis.Orthopedic nursing, 9 2
Peter McIntyre, R. Jepson, S. Leeder, L. Irwig (1993)
A population based studyMedical Journal of Australia, 159
O. Pamuk, E. Unlü, N. Çakır (2006)
Role of insulin resistance in increased frequency of atherosclerosis detected by carotid ultrasonography in rheumatoid arthritis.The Journal of rheumatology, 33 12
G. Kitas, N. Erb (2003)
Tackling ischaemic heart disease in rheumatoid arthritis.Rheumatology, 42 5
L. Freedman, D. Pee (1989)
Return to a Note on Screening Regression EquationsThe American Statistician, 43
H. Maradit-Kremers, P. Nicola, C. Crowson, Karla Ballman, S. Gabriel (2005)
Cardiovascular death in rheumatoid arthritis: a population-based study.Arthritis and rheumatism, 52 3
N. Denarié, J. Gariépy, G. Chironi, M. Massonneau, F. Laskri, J. Salomon, J. Levenson, A. Simon (2000)
Distribution of ultrasonographically-assessed dimensions of common carotid arteries in healthy adults of both sexes.Atherosclerosis, 148 2
S. Rantapää-Dahlqvist, S. Wållberg-Jonsson (1991)
Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis.Annals of the Rheumatic Diseases, 50
T. Wallace, J. Levy, D. Matthews (2004)
Use and abuse of HOMA modeling.Diabetes care, 27 6
P. Dessein, B. Joffe, A. Stanwix, B. Christian, M. Veller (2004)
Glucocorticoids and insulin sensitivity in rheumatoid arthritis.The Journal of rheumatology, 31 5
M. Prevoo, M. Hof, H. Kuper, M. Leeuwen, L. Putte, P. Riel (1995)
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.Arthritis and rheumatism, 38 1
D. Solomon, E. Karlson, E. Rimm, C. Cannuscio, L. Mandl, J. Manson, M. Stampfer, G. Curhan (2003)
Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid ArthritisCirculation: Journal of the American Heart Association, 107
I. Rincón, G. Freeman, Roy Haas, D. O'leary, A. Escalante (2005)
Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis.Arthritis and rheumatism, 52 11
K. Svenson, T. Pollare, H. Lithell, Roger Hällgren (1988)
Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance.Metabolism: clinical and experimental, 37 2
P. Dessein, B. Joffe, M. Veller, B. Stevens, M. Tobias, K. Reddi, A. Stanwix (2005)
Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis.The Journal of rheumatology, 32 3
The objective of this study was to investigate the relationship between insulin resistance (IR) and sub-clinical atherosclerosis in patients with rheumatoid arthritis (RA).Carotid artery intima media thickness (IMT), using ultrasound evaluation, and other clinical and laboratory variables were investigated in 45 RA outpatients and in 48 controls with soft tissue disorders. IR was assayed by homeostasis model assessment (HOMA2) and metabolic syndrome by National Cholesterol Education Program Adult Treatment Panel (NCEP ATP III) criteria.Insulin resistance, as defined by HOMA2-IR>1, was seen in 40 (88.9%) RA patients and in three (6.2%) controls (p<0.001). No significant difference was detected in the prevalence of metabolic syndrome. The median IMT was greater in RA patients (0.76 mm; interquartile range [IQR] 0.65, 0.85) than in the controls (0.66 mm; IQR 0.60, 0.72) (p<0.001). Dividing the RA patients according to the cut-off IMT value (0.72 mm), a difference was detected in both systolic (p=0.04) and diastolic blood pressure (p=0.02), disease activity score (DAS28) (p=0.008), HOMA2-IR (p<0.001) and cumulative oral steroid dose (p=0.001). Moreover, the frequency of cases with increased IMT was higher in glucocorticoid users than in non-users (21/23 vs. 9/22, respectively) (p<0.001). Spearman's rho correlation showed a significant positive relationship between IMT and HOMA2-IR (p<0.001). Multivariate stepwise analysis selected HOMA2-IR plus diastolic BP plus glucocorticoid exposure as the best predictive model for subclinical atherosclerosis (R2c=0.577, F=21, p<0.001).In conclusion, this study showed a significantly higher prevalence of IR in RA patients and pointed out a significant association between IR and subclinical atherosclerosis. This relationship may be driven primarily by exposure to steroid therapy.
Diabetes and Vascular Disease Research – SAGE
Published: Jun 1, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.